Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mast Cells as Drivers of Disease and Therapeutic Targets.
Siebenhaar F, Redegeld FA, Bischoff SC, Gibbs BF, Maurer M. Siebenhaar F, et al. Among authors: gibbs bf. Trends Immunol. 2018 Feb;39(2):151-162. doi: 10.1016/j.it.2017.10.005. Epub 2017 Nov 28. Trends Immunol. 2018. PMID: 29196147 Review.
Endocannabinoids limit excessive mast cell maturation and activation in human skin.
Sugawara K, Bíró T, Tsuruta D, Tóth BI, Kromminga A, Zákány N, Zimmer A, Funk W, Gibbs BF, Zimmer A, Paus R. Sugawara K, et al. Among authors: gibbs bf. J Allergy Clin Immunol. 2012 Mar;129(3):726-738.e8. doi: 10.1016/j.jaci.2011.11.009. Epub 2012 Jan 9. J Allergy Clin Immunol. 2012. PMID: 22226549
Anti-Fas/CD95 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) differentially regulate apoptosis in normal and neoplastic human basophils.
Förster A, Falcone FH, Gibbs BF, Preussner LM, Fiebig BS, Altunok H, Seeger JM, Cerny-Reiterer S, Rabenhorst A, Papenfuss K, Valent P, Kashkar H, Hartmann K. Förster A, et al. Among authors: gibbs bf. Leuk Lymphoma. 2013 Apr;54(4):835-42. doi: 10.3109/10428194.2012.731600. Epub 2012 Oct 9. Leuk Lymphoma. 2013. PMID: 22989017
172 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page